Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Equity Commonwealth D Pref | EQC-D | Jan 15, 2025 | 25.05 | 0.00 |
Equity Income Wisdomtree | DHS | Jan 15, 2025 | 93.80 | +0.70 |
Equity Lifestyle Properties | ELS | Jan 15, 2025 | 64.36 | -0.97 |
Equity Residential | EQR | Jan 15, 2025 | 69.46 | -0.66 |
Equus Total Return | EQS | Jan 15, 2025 | 1.27 | +1.36 |
EQV Ventures Acquisition | EQV | Jan 15, 2025 | 9.99 | 0.00 |
Erasca | ERAS | Jan 15, 2025 | 1.92 | -0.26 |
Erayak Power Solution Group A | RAYA | Jan 15, 2025 | 1.27 | -0.78 |
Ericsson B ADR | ERIC | Jan 15, 2025 | 8.54 | +3.89 |
Erie Indemnity A | ERIE | Jan 15, 2025 | 400.18 | +0.10 |
Ermenegildo Zegna N.V. | ZGN | Jan 15, 2025 | 7.69 | +0.92 |
Ero Copper | ERO | Jan 15, 2025 | 14.18 | +1.65 |
ESAB | ESAB | Jan 15, 2025 | 121.07 | +0.85 |
Escalade | ESCA | Jan 15, 2025 | 14.96 | +2.12 |
Esco Technologies | ESE | Jan 15, 2025 | 132.83 | +0.17 |
ESGL | ESGL | Jan 15, 2025 | 1.23 | -1.60 |
ESH Acquisition | ESHA | Jan 15, 2025 | 10.77 | 0.00 |
Eshallgo | EHGO | Jan 15, 2025 | 1.08 | -6.90 |
Esperion Therapeutics | ESPR | Jan 15, 2025 | 2.21 | -1.34 |
Espey Mfg & Electronics | ESP | Jan 15, 2025 | 28.49 | +3.00 |
Esquire Financial | ESQ | Jan 15, 2025 | 83.24 | +3.74 |
ESS Tech | GWH | Jan 15, 2025 | 5.15 | +0.98 |
ESSA Bancorp | ESSA | Jan 15, 2025 | 19.60 | +0.51 |
ESSA Pharma | EPIX | Jan 15, 2025 | 1.76 | -0.57 |
Essent Group | ESNT | Jan 15, 2025 | 57.66 | +1.87 |
Essential Properties Realty Trust | EPRT | Jan 15, 2025 | 31.06 | +0.19 |
Essential Utilities | WTRG | Jan 15, 2025 | 34.49 | +1.11 |
Essex Property Trust | ESS | Jan 15, 2025 | 282.85 | -0.57 |
Establishment Labs | ESTA | Jan 15, 2025 | 34.65 | +4.52 |
Estee Lauder Companies | EL | Jan 15, 2025 | 74.52 | +0.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.